PPRCH-15 - Why do patients stop taking their glucagon-like peptide-1 receptor agonists?

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: PPRCH-15
• By: LIU, Shania (EPICORE, Department of Medicine, Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, Canada)
• Co-author(s): Dr Shania Liu (EPICORE, Department of Medicine, Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada)
  Genieve Wong (EPICORE, Department of Medicine, Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada)
  Pavneet Mavi (EPICORE, Department of Medicine, Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada)
  Daniel Burton (EPICORE, Department of Medicine, Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada)
  Neire Monteiro
  Derek Durocher
  Dr Ross Tsuyuki (EPICORE, Department of Medicine, Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada / Department of Medicine, Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada / Department of Pharmacology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada)
  Dr Stephanie Gysel (EPICORE, Department of Medicine, Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada / Apothecare Pharmacy Calgary, Alberta, Canada)
  
• Abstract:

  Introduction: Type 2 diabetes and obesity are among leading causes of morbidity and mortality worldwide. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are effective for the management of type 2 diabetes and overweight or obesity, but effectiveness of therapy is compromised by high rates of non-persistence. The objective of this study was to ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login